521 related articles for article (PubMed ID: 26368040)
21. Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives.
El-Damasy AK; Seo SH; Cho NC; Kang SB; Pae AN; Kim KS; Keum G
Eur J Med Chem; 2015 Aug; 101():754-68. PubMed ID: 26218653
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antiproliferative activity of benzofuran-based analogs of cercosporamide against non-small cell lung cancer cell lines.
Bazin MA; Bodero L; Tomasoni C; Rousseau B; Roussakis C; Marchand P
Eur J Med Chem; 2013 Nov; 69():823-32. PubMed ID: 24121233
[TBL] [Abstract][Full Text] [Related]
23. New imidazo[1,2-b]pyrazoles as anticancer agents: synthesis, biological evaluation and structure activity relationship analysis.
Grosse S; Mathieu V; Pillard C; Massip S; Marchivie M; Jarry C; Bernard P; Kiss R; Guillaumet G
Eur J Med Chem; 2014 Sep; 84():718-30. PubMed ID: 25064349
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterization and in vitro anticancer evaluation of novel 1,2,4-triazolin-3-one derivatives.
Kattimani PP; Kamble RR; Kariduraganavar MY; Dorababu A; Hunnur RK
Eur J Med Chem; 2013 Apr; 62():232-40. PubMed ID: 23353755
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of new pyrazole derivatives and their anticancer evaluation.
Nitulescu GM; Draghici C; Missir AV
Eur J Med Chem; 2010 Nov; 45(11):4914-9. PubMed ID: 20728965
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL
Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, antiproliferative activities and in vitro biological evaluation of novel benzofuransulfonamide derivatives.
Yang L; Lei H; Mi CG; Liu H; Zhou T; Zhao YL; Lai XY; Li ZC; Song H; Huang WC
Bioorg Med Chem Lett; 2011 Sep; 21(18):5389-92. PubMed ID: 21795045
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological evaluation of 2-mercapto-3-phenethylquinazoline bearing anilide fragments as potential antitumor agents: molecular docking study.
Al-Suwaidan IA; Alanazi AM; Abdel-Aziz AA; Mohamed MA; El-Azab AS
Bioorg Med Chem Lett; 2013 Jul; 23(13):3935-41. PubMed ID: 23683592
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, antitumor activity and molecular docking study of novel benzofuran-2-yl pyrazole pyrimidine derivatives.
El-Zahar MI; Adb El-Karim SS; Haiba ME; Khedr MA
Acta Pol Pharm; 2011; 68(3):357-73. PubMed ID: 21648190
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.
Qin YJ; Li YJ; Jiang AQ; Yang MR; Zhu QZ; Dong H; Zhu HL
Eur J Med Chem; 2015 Apr; 94():447-57. PubMed ID: 25828827
[TBL] [Abstract][Full Text] [Related]
31. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors.
Akhtar MJ; Khan AA; Ali Z; Dewangan RP; Rafi M; Hassan MQ; Akhtar MS; Siddiqui AA; Partap S; Pasha S; Yar MS
Bioorg Chem; 2018 Aug; 78():158-169. PubMed ID: 29571113
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of 1,3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents.
Reddy TS; Kulhari H; Reddy VG; Bansal V; Kamal A; Shukla R
Eur J Med Chem; 2015 Aug; 101():790-805. PubMed ID: 26231080
[TBL] [Abstract][Full Text] [Related]
35. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
Kassab AE; Hassan RA
Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
[TBL] [Abstract][Full Text] [Related]
36. Design and biological evaluation of novel hybrids of 1, 5-diarylpyrazole and Chrysin for selective COX-2 inhibition.
Ren SZ; Wang ZC; Zhu XH; Zhu D; Li Z; Shen FQ; Duan YT; Cao H; Zhao J; Zhu HL
Bioorg Med Chem; 2018 Aug; 26(14):4264-4275. PubMed ID: 30031652
[TBL] [Abstract][Full Text] [Related]
37. Rational synthesis, anticancer activity, and molecular docking studies of novel benzofuran liked thiazole hybrids.
Hadiyal SD; Lalpara JN; Dhaduk BB; Joshi HS
Mol Divers; 2023 Jun; 27(3):1345-1357. PubMed ID: 35852708
[TBL] [Abstract][Full Text] [Related]
38. Biological Validation of Novel Polysubstituted Pyrazole Candidates with in Vitro Anticancer Activities.
Fahmy HH; Khalifa NM; Ismail MM; El-Sahrawy HM; Nossier ES
Molecules; 2016 Feb; 21(3):271. PubMed ID: 26927048
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and anticancer activity of novel hybrid compounds between benzofuran and N-aryl piperazine.
Mao ZW; Zheng X; Lin YP; Hu CY; Wang XL; Wan CP; Rao GX
Bioorg Med Chem Lett; 2016 Aug; 26(15):3421-4. PubMed ID: 27371110
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents.
Alanazi AM; Abdel-Aziz AA; Al-Suwaidan IA; Abdel-Hamide SG; Shawer TZ; El-Azab AS
Eur J Med Chem; 2014 May; 79():446-54. PubMed ID: 24763265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]